» Articles » PMID: 31048445

Genetic Associations Between Genes in the Renin-angiotensin-aldosterone System and Renal Disease: a Systematic Review and Meta-analysis

Overview
Journal BMJ Open
Specialty General Medicine
Date 2019 May 4
PMID 31048445
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic kidney disease (CKD) is defined by abnormalities in kidney structure and/or function present for more than 3 months. Worldwide, both the incidence and prevalence rates of CKD are increasing. The renin-angiotensin-aldosterone system (RAAS) regulates fluid and electrolyte balance through the kidney. RAAS activation is associated with hypertension, which is directly implicated in causation and progression of CKD. RAAS blockade, using drugs targeting individual RAAS mediators and receptors, has proven to be renoprotective.

Objectives: To assess genomic variants present within RAAS genes, , , , , and , for association with CKD.

Design And Data Sources: A systematic review and meta-analysis of observational research was performed to evaluate the RAAS gene polymorphisms in CKD using both PubMed and Web of Science databases with publication date between the inception of each database and 31 December 2018. Eligible articles included case-control studies of a defined kidney disease and included genotype counts.

Eligibility Criteria: Any paper was removed from the analysis if it was not written in English or Spanish, was a non-human study, was a paediatric study, was not a case-control study, did not have a renal disease phenotype, did not include data for the genes, was a gene expression-based study or had a pharmaceutical drug focus.

Results: A total of 3531 studies were identified, 114 of which met the inclusion criteria. Genetic variants reported in at least three independent publications for populations with the same ethnicity were determined and quantitative analyses performed. Three variants returned significant results in populations with different ethnicities at p<0.05: insertion, rs699-T allele and rs5186-A allele; each variant was associated with a reduced risk of CKD development.

Conclusions: Further biological pathway and functional analyses of the RAAS gene polymorphisms will help define how variation in components of the RAAS pathway contributes to CKD.

Citing Articles

The study of single nucleotide polymorphism in a promoter region of ACE-2 receptor gene in the samples of Iraqi population with COVID-19.

Mahmood A, Al-Awadi S, Hadi N, Al-Attar M Mol Biol Rep. 2024; 51(1):839.

PMID: 39042234 DOI: 10.1007/s11033-024-09785-y.


Sour Tamarind Is More Antihypertensive than the Sweeter One, as Evidenced by In Vivo Biochemical Indexes, Ligand-Protein Interactions, Multitarget Interactions, and Molecular Dynamic Simulation.

Akter T, Bulbul M, Sama-Ae I, Azadi M, Nira K, Al-Araby S Nutrients. 2023; 15(15).

PMID: 37571339 PMC: 10420995. DOI: 10.3390/nu15153402.


Epigenome-wide association study of diabetic chronic kidney disease progression in the Korean population: the KNOW-CKD study.

Sung H, Lee S, Han M, An W, Ryu H, Kang E Sci Rep. 2023; 13(1):8175.

PMID: 37210443 PMC: 10199928. DOI: 10.1038/s41598-023-35485-x.


The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes.

Ranjbar T, Oza P, Kashfi K Int J Mol Sci. 2022; 23(22).

PMID: 36430371 PMC: 9699619. DOI: 10.3390/ijms232213895.


Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options.

Pelle M, Zaffina I, Luca S, Forte V, Trapanese V, Melina M Life (Basel). 2022; 12(10).

PMID: 36295042 PMC: 9604693. DOI: 10.3390/life12101605.


References
1.
Lau Y, Woo K, Choong H, Zhao Y, Tan H, Chong S . Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore. Nephron Physiol. 2004; 97(1):p1-8. DOI: 10.1159/000077596. View

2.
Smyth L, Duffy S, Maxwell A, McKnight A . Genetic and epigenetic factors influencing chronic kidney disease. Am J Physiol Renal Physiol. 2014; 307(7):F757-76. DOI: 10.1152/ajprenal.00306.2014. View

3.
Mills K, Xu Y, Zhang W, Bundy J, Chen C, Kelly T . A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015; 88(5):950-7. PMC: 4653075. DOI: 10.1038/ki.2015.230. View

4.
Nishiyama A, Kim-Mitsuyama S . New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin-angiotensin-aldosterone system. J Pharmacol Sci. 2010; 113(4):289-91. DOI: 10.1254/jphs.10r03fm. View

5.
Yamout H, Lazich I, Bakris G . Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease. Adv Chronic Kidney Dis. 2014; 21(3):281-6. DOI: 10.1053/j.ackd.2014.03.005. View